DOCSLIB.ORG

Extracellular Matrix Alterations in Human Corneas with Bullous Keratopathy

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Extracellular Matrix Alterations in Human Corneas With Bullous Keratopathy Alexander V. Ljubimov,* Robert E. Burgeson,^ Ralph J. Butkowski,% John R Couchman,\ Rong Rong Wu,§ Yoshifumi Ninomiya,\\ Yoshikazu Sado,\ Ezra Maguen,* Anthony B. Nesburn,* and M. Cristina Kenney* Purpose. To uncover abnormalities of extracellular matrix (ECM) distribution in human cor- neas with pseudophakic and aphakic bullous keratopathy (PBK/ABK). Methods. Indirect immunofluorescence with antibodies to 27 ECM components was used on frozen sections of 14 normal and 20 PBK/ABK corneas. Results. Fibrillar deposits of an antiadhesive glycoprotein tenascin in the anterior and posterior stroma, epithelial basement membrane (BM), bullae and subepithelial fibrosis (SEF) areas, and posterior collagenous layer (PCL) were revealed in diseased corneas. Tenascin in midstroma, which was observed in some cases, correlated with decreased visual acuity. In normal central corneas, tenascin was never found. Other major ECM abnormalities in PBK/ ABK corneas compared to normals included: discontinuous epithelial BM staining for laminin- 1 (aipiyl), entactin/nidogen and fibronectin; accumulation of fibronectin and al-a2 type IV collagen on the endothelial face of the Descemet's membrane; and abnormal deposition of stromal ECM (tenascin, fibronectin, decorin, types I, III, V, VI, VIII, XII, XIV collagen) and BM components (type IV collagen, perlecan, bamacan, laminin-1, entactin-nidogen, fibronectin) in SEF areas and in PCL. Conclusions. This study provides a molecular description of an ongoing fibrosis on the epithe- lial, stromal, and endothelial levels in PBK/ABK corneas. These fibrotic changes may follow initial endothelial damage after cataract surgery, may be caused by the upregulation of fibro- genic cytokines, and may play a significant role in the progression of bullous keratopathy. Invest Ophthalmol Vis Sci. 1996; 37:997-1007. X seudophakic (PBK) and aphakic (ABK) bullous ker- mal accumulation of fluid with formation of fluid- atopathy are complications of cataract surgery with filled lakes.2'3 The epithelial edema causes "blisters" (PBK) or without (ABK) intraocular lens placement. or bullae on the epithelial surface that can rupture, Together, they are a leading indication for corneal cause pain, and interfere with vision. In advanced transplantation.1 Both are characterized by chronic cases, subepithelial fibrosis (SEF), formation of a pos- corneal edema and loss of transparency. Progressive terior collagenous layer (PCL; also known as retrocor- stromal thickening seems to be caused by the intrastro- neal fibrous membrane) between the epithelial cell layer and Descemet's membrane (DM), and corneal From the *Ophthalmology Research Laboratories, Cedars-Sinai Medical Center, vascularization can occur. Clinically, pathologically, UCLA Medical School Affiliate (Los Angeles, CA); the fMGH-Harvard Cutaneous Biology Research Center, Massachusetts General Hospital (Charlestown, MA); the and histologically, PBK and ABK are similar to each 4 6 XINCSTAR Corporation (Stillwater, MN); the ^Department of Cell Biology, other " and are categorized separately based only on University of Alabama at Birmingham; the \\Okayama University Medical School and the ^Shigei Medical Research Institute (Okayama, Japan). the presence or absence of an intraocular lens. Thus, Presented in part at the annual meeting of the Association for Research in Vision we think it reasonable to refer to them here as one and Ophthalmology, Fort Lauderdale, Florida, May 1995. Supported by National Institutes of Health grants EY10836 (MCK), AR36457 disease (PBK/ABK). (JRC), the Skirball Program in Molecular Ophthalmology (AVL), the Discovery Chronic edema in PBK/ABK corneas results from Fund for Eye Research (AVL, MCK), and the Helen Keller Eye Research Foundation (RRW). JRC is an Established Investigator of the American Heart Association. decreased ability of endothelial cells to remove fluid. Proprietary interest category: N. Reprint requests: Alexander V. Ljubimov, Cedars-Sinai Medical Center, Davis- This is caused by a persistent decrease in the endothe- 5069, 8700 Beverly Boulevard, Los Angeles, CA 90048. lial cell number after the cell damage during cataract Investigative Ophthalmology & Visual Science, May 1996, Vol. 37, No. 6 Copyright © Association for Research in Vision and Ophthalmology 997 Downloaded from iovs.arvojournals.org on 09/27/2021 998 Investigative Ophthalmology & Visual Science, May 1996, Vol. 37, No. 6 surgery,7"9 to an alteration of the pumping capacity Research Interchange (Philadelphia, PA). PBK/ABK of these cells,7'8'10 or both. The damaged endothelium corneas (n = 20, Table 1) were obtained within 20 can close the initial defect over time, but, in some hours of penetrating keratoplasty. In each case, the cases, the defect persists, leading to the development histologic diagnosis was verified by a pathologist. Cor- of PBK/ABK. As a potential therapy, transplantation neal embedding in OCT compound (Miles, Elkhart, of normal corneal endothelium onto its basement IN), sectioning, indirect immunofiuorescence, and membrane (DM) has been considered.11'12 However, photography were performed as described.16 Results normal endothelium grows well on normal DM but of routine specificity controls16 were negative. Statisti- does not spread and grow well on PBK DM.13 The cal analysis was performed using two-sided Fisher's diseased DM thus provides a poor substrate for the exact test. cells. A reduction of endothelial cell number may be Antibodies to human al-ab chains of type IV an important early event in the PBK/ABK develop- collagen; to al (A), «2 (M), aS (K), /ft (Bl), j32 (S), ment. Later, changes of the cell phenotype may occur, /33 (kalinin Bl), and yl (B2) chains of laminin; to leading to the formation of a growth-restricting extra- entactin/nidogen, types VII, XII, and XIV collagen, cellular matrix (ECM) that precludes endothelial rees- perlecan core protein domain IV (clones A7L6 and tablishment. C11L1); and to fibronectin have been described in 16 18 Endothelial cell dysfunction also may contribute detail. " Affinity-purified polyclonal antibodies to to corneal edema in PBK/ABK. These cells maintain recombinant rat bamacan (basement membrane 19 corneal hydration through the Na+/K+ ATPase pump. chondroitin sulfate proteoglycan ) core protein, Corneal endothelial cells in PBK/ABK have reduced cross-reacted with human, were produced in rabbits pump site density compared to normals.10 This func- (Couchman et al, manuscript in preparation). A tional impairment may be a secondary event in PBK/ monoclonal antibody to the aS chain of human type ABK. VI collagen (clone 3C4) was a gift from Dr. E. Engvall Several lines of evidence emphasize the impor- (Lajolla Cancer Research Foundation, Lajolla, CA). tance of ECM changes in PBK/ABK development: Polyclonal antibodies to human types I, III, and V collagen were obtained from Southern Biotechnology 1. Typically, PBK/ABK corneas develop ECM accu- (Birmingham, AL); polyclonal antibodies to human mulation at the endothelial (PCL) and the epi- 4 6 decorin and a monoclonal antibody to human tenas- thelial (SEF) levels. " cin (clone TN-2) were obtained from Chemicon Inter- 2. Corneal epithelial basement membrane (BM) in national (Temecula, CA); a monoclonal antibody to PBK/ABK lacks fibronectin, laminin, and type 14 human vimentin (clone Vim 3B4) was obtained from IV collagen, which might reduce cell adhesion Boehringer Mannheim (Indianapolis, IN); a mono- and facilitate bullae formation. clonal antibody to cellular fibronectin (clone IST-9) 3. PBK DM shows altered collagen content and lec- was obtained from Sera-Lab (Crawley Down, UK); a tin binding15 and, contrary to normal DM, does 13 monoclonal antibody to the al chain of bovine-hu- not support cell growth, suggesting structural man type VIII collagen (clone 9H3) was obtained from alterations, compositional alterations, or both. Seikagaku America (Rockville, MD); a polyclonal anti- Despite these findings, the ECM of PBK/ABK cor- body to human von Willebrand factor, a mixture of neas has not been studied systematically. monoclonal antibodies to human keratins (pankera- We report here on the detailed characterization tin cocktail), and a monoclonal antibody to human a- of the ECM and BM composition of PBK/ABK corneas smooth muscle actin (clone 1A4) were all obtained with antibodies to 27 individual ECM components. from Sigma Chemical (St. Louis, MO). Cross-species- Compared to normal corneas, there was an accumula- adsorbed fluorescein- and rhodamine-conjugated sec- tion of stromal tenascin and alterations of epithelial ondary antibodies were obtained from Chemicon In- BM and DM. We also describe the molecular and cellu- ternational. lar composition of PCL and SEF areas. Our results provide the documentation of significant fibrotic changes in PBK/ABK corneas on the molecular level, even in cases in which no PCL or SEF could be found. RESULTS We think PBK/ABK not only is a disease of chronic All PBK/ABK corneal buttons studied represented edema but has an ongoing fibrosis that plays an im- only the central corneal part, so their epithelial BM portant role in its pathology. structure was compared with that of normal central corneas only (see16 for differences of the epithelial BM MATERIALS AND METHODS composition in normal central cornea and limbus). In Normal adult human corneas (n = 14) were obtained PBK/ABK corneas and failed corneal grafts of pseu- within 36 hours of death from the National
Recommended publications
  • Bruch's Membrane Abnormalities in PRDM5-Related Brittle Cornea

    Bruch's Membrane Abnormalities in PRDM5-Related Brittle Cornea

    Porter et al. Orphanet Journal of Rare Diseases (2015) 10:145 DOI 10.1186/s13023-015-0360-4 RESEARCH Open Access Bruch’s membrane abnormalities in PRDM5-related brittle cornea syndrome Louise F. Porter1,2,3, Roberto Gallego-Pinazo4, Catherine L. Keeling5, Martyna Kamieniorz5, Nicoletta Zoppi6, Marina Colombi6, Cecilia Giunta7, Richard Bonshek2,8, Forbes D. Manson1 and Graeme C. Black1,9* Abstract Background: Brittle cornea syndrome (BCS) is a rare, generalized connective tissue disorder associated with extreme corneal thinning and a high risk of corneal rupture. Recessive mutations in transcription factors ZNF469 and PRDM5 cause BCS. Both transcription factors are suggested to act on a common pathway regulating extracellular matrix genes, particularly fibrillar collagens. We identified bilateral myopic choroidal neovascularization as the presenting feature of BCS in a 26-year-old-woman carrying a novel PRDM5 mutation (p.Glu134*). We performed immunohistochemistry of anterior and posterior segment ocular tissues, as expression of PRDM5 in the eye has not been described, or the effects of PRDM5-associated disease on the retina, particularly the extracellular matrix composition of Bruch’smembrane. Methods: Immunohistochemistry using antibodies against PRDM5, collagens type I, III, and IV was performed on the eyes of two unaffected controls and two patients (both with Δ9-14 PRDM5). Expression of collagens, integrins, tenascin and fibronectin in skin fibroblasts of a BCS patient with a novel p.Glu134* PRDM5 mutation was assessed using immunofluorescence. Results: PRDM5 is expressed in the corneal epithelium and retina. We observe reduced expression of major components of Bruch’s membrane in the eyes of two BCS patients with a PRDM5 Δ9-14 mutation.
  • Vascular Phenotypes in Nonvascular Subtypes of the Ehlers-Danlos Syndrome: a Systematic Review

    Vascular Phenotypes in Nonvascular Subtypes of the Ehlers-Danlos Syndrome: a Systematic Review

    SYSTEMATIC REVIEW Official journal of the American College of Medical Genetics and Genomics Vascular phenotypes in nonvascular subtypes of the Ehlers-Danlos syndrome: a systematic review Sanne D’hondt, MSc1, Tim Van Damme, MD1 and Fransiska Malfait, MD, PhD1 Purpose: Within the spectrum of the Ehlers-Danlos syndromes (53%), frequently reported in musculocontractural and classical- (EDS), vascular complications are usually associated with the like EDS; intracranial hemorrhages (18%), with a high risk in vascular subtype of EDS. Vascular complications are also observed dermatosparaxis EDS; and arterial dissections (16%), frequently in other EDS subtypes, but the reports are anecdotal and the reported in kyphoscoliotic and classical EDS. Other, more minor, information is dispersed. To better document the nature of vascular vascular complications were reported in cardiac-valvular, arthro- complications among “nonvascular” EDS subtypes, we performed chalasia, spondylodysplastic, and periodontal EDS. a systematic review. Conclusion: Potentially life-threatening vascular complications are Methods: We queried three databases for English-language a rare but important finding in several nonvascular EDS sub- studies from inception until May 2017, documenting both types, highlighting a need for more systematic documentation. This phenotypes and genotypes of patients with nonvascular EDS review will help familiarize clinicians with the spectrum of vascular subtypes. The outcome included the number and nature of vascular complications in EDS and guide follow-up and management. complications. Genet Med advance online publication 5 October 2017 Results: A total of 112 papers were included and data were collected from 467 patients, of whom 77 presented with a vascular Key Words: connective tissue disorder; Ehlers-Danlos syndrome; phenotype.
  • Reduction of Type V Collagen Using a Dominant-Negative

    Reduction of Type V Collagen Using a Dominant-Negative

    CORE Metadata, citation and similar papers at core.ac.uk Provided by PubMed Central Reduction of Type V Collagen Using a Dominant-negative Strategy Alters the Regulation of Fibrillogenesis and Results in the Loss of Corneal-Specific Fibril Morphology Jeffrey K. Marchant, Rita A. Hahn, Thomas F. Linsenmayer, and David E. Birk Department of Anatomy and Cellular Biology, Tufts University School of Medicine, Boston, Massachusetts 02111 Abstract. A number of factors have been implicated in synthesized the truncated or(V) protein, and this was the regulation of tissue-specific collagen fibril diameter. detectable only intracellularly, in a distribution that Previous data suggest that assembly of heterotypic colocalized with lysosomes. To assess endogenous fibrils composed of two different fibrillar collagens rep- etl(V) protein levels, infected cell cultures were as- resents a general mechanism regulating fibril diameter. sayed, and these consistently demonstrated reductions Specifically, we hypothesize that type V collagen is re- relative to control virus-infected or uninfected cultures. quired for the assembly of the small diameter fibrils ob- Analyses of corneal fibril morphology demonstrated served in the cornea. To test this, we used a dominant- that the reduction in type V collagen resulted in the as- negative retroviral strategy to decrease the levels of sembly of large-diameter fibrils with a broad size distri- type V collagen secreted by chicken corneal fibroblasts. bution, characteristics similar to fibrils produced in The chicken or(V) collagen gene was cloned, and ret- connective tissues with low type V concentrations. Im- roviral vectors that expressed a polycistronic mRNA munoelectron microscopy demonstrated the amino- encoding a truncated otl(V) minigene and the reporter terminal domain of type V collagen was associated with gene LacZ were constructed.
  • Understanding the Basis of Ehlers–Danlos Syndrome in the Era of the Next-Generation Sequencing

    Understanding the Basis of Ehlers–Danlos Syndrome in the Era of the Next-Generation Sequencing

    Archives of Dermatological Research (2019) 311:265–275 https://doi.org/10.1007/s00403-019-01894-0 REVIEW Understanding the basis of Ehlers–Danlos syndrome in the era of the next-generation sequencing Francesca Cortini1,2 · Chiara Villa3 · Barbara Marinelli1 · Romina Combi3 · Angela Cecilia Pesatori1 · Alessandra Bassotti4 Received: 29 July 2018 / Revised: 26 November 2018 / Accepted: 12 February 2019 / Published online: 2 March 2019 © Springer-Verlag GmbH Germany, part of Springer Nature 2019 Abstract Ehlers–Danlos syndrome (EDS) is a clinically and genetically heterogeneous group of heritable connective tissue disorders (HCTDs) defined by joint laxity, skin alterations, and joint hypermobility. The latest EDS classification recognized 13 sub- types in which the clinical and genetic phenotypes are often overlapping, making the diagnosis rather difficult and strength- ening the importance of the molecular diagnostic confirmation. New genetic techniques such as next-generation sequencing (NGS) gave the opportunity to identify the genetic bases of unresolved EDS types and support clinical counseling. To date, the molecular defects have been identified in 19 genes, mainly in those encoding collagen, its modifying enzymes or other constituents of the extracellular matrix (ECM). In this review we summarize the contribution of NGS technologies to the current knowledge of the genetic background in different EDS subtypes. Keywords Ehlers–Danlos syndrome · Heterogeneity · Heritable connective tissue disorders Introduction in 1988, represents the first attempt to classify EDS, recog- nizing 11 EDS subtypes [4], defined by Roman numerals and Ehlers–Danlos syndrome (EDS) comprises a clinically and classified according to clinical findings and the inheritance heterogeneous group of heritable connective tissue disor- pattern.
  • Characterization of Collagen Fibers (I, III, IV) and Elastin of Normal and Neoplastic Canine Prostatic Tissues

    Characterization of Collagen Fibers (I, III, IV) and Elastin of Normal and Neoplastic Canine Prostatic Tissues

    veterinary sciences Article Characterization of Collagen Fibers (I, III, IV) and Elastin of Normal and Neoplastic Canine Prostatic Tissues Luis Gabriel Rivera Calderón 1, Priscila Emiko Kobayashi 2, Rosemeri Oliveira Vasconcelos 1, Carlos Eduardo Fonseca-Alves 3 and Renée Laufer-Amorim 2,* 1 Department of Veterinary Pathology, School of Agricultural and Veterinarian Sciences, São Paulo State University (Unesp), Jaboticabal, São Paulo 14884-900, Brazil; [email protected] (L.G.R.C.); [email protected] (R.O.V.) 2 Department of Veterinary Clinic, School of Veterinary Medicine and Animal Science, São Paulo State University (Unesp), Botucatu, São Paulo 18618-681, Brazil; [email protected] 3 Department of Veterinary Surgery and Anesthesiology, School of Veterinary Medicine and Animal Science, São Paulo State University (Unesp), Botucatu, São Paulo 18618-681, Brazil; [email protected] * Correspondence: [email protected]; Tel.: +55-14-3880-2076 Received: 7 January 2019; Accepted: 25 February 2019; Published: 2 March 2019 Abstract: This study aimed to investigate collagen (Coll-I, III, IV) and elastin in canine normal prostate and prostate cancer (PC) using Picrosirius red (PSR) and Immunohistochemical (IHC) analysis. Eight normal prostates and 10 PC from formalin-fixed, paraffin-embedded samples were used. Collagen fibers area was analyzed with ImageJ software. The distribution of Coll-I and Coll-III was approximately 80% around prostatic ducts and acini, 15% among smooth muscle, and 5% surrounding blood vessels, in both normal prostate and PC. There was a higher median area of Coll-III in PC when compared to normal prostatic tissue (p = 0.001 for PSR and p = 0.05 for IHC).
  • Collagen Tissue Engineering: Development of Novel Biomaterials and Applications

    Collagen Tissue Engineering: Development of Novel Biomaterials and Applications

    0031-3998/08/6305-0492 Vol. 63, No. 5, 2008 PEDIATRIC RESEARCH Printed in U.S.A. Copyright © 2008 International Pediatric Research Foundation, Inc. Collagen Tissue Engineering: Development of Novel Biomaterials and Applications LIAN CEN, WEI LIU, LEI CUI, WENJIE ZHANG, AND YILIN CAO Department of Plastic and Reconstructive Surgery [W.L., L.C., W.Z., Y.C.], Shanghai 9th People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, China; National Tissue Engineering Center of China [L.C., W.L., L.C., W.Z., Y.C.], Shanghai 200235, China ABSTRACT: Scientific investigations involving collagen have in- regeneration is to restore both the structural integrity and the spired tissue engineering and design of biomaterials since collagen vivid remodeling process of native ECM, especially restoring the fibrils and their networks primarily regulate and define most tissues. delicate collagen networks under which normal physiologic re- The collagen networks form a highly organized, three-dimensional generation occurs. architecture to entrap other ingredients. Biomaterials are expected to Collagen molecules have a triple-helical structure and the function as cell scaffolds to replace native collagen-based extracel- lular matrix. The composition and properties of biomaterials used as presence of 4-hydroxyproline resulting from a posttransla- scaffold for tissue engineering significantly affect the regeneration of tional modification of peptide-bound prolyl residues provides neo-tissues and influence the conditions of collagen engineering. The a distinctive marker of these molecules (2). To date, 28 complex scenario of collagen characteristics, types, fibril arrange- collagen types have been identified; I, II, III, and V are the ment, and collagen structure-related functions (in a variety of con- main types that make up the essential part of collagen in bone, nective tissues including bone, cartilage, tendon, skin and cornea) are cartilage, tendon, skin, and muscle.
  • Collagen Type I and Decorin Expression in Tenocytes Depend On

    Collagen Type I and Decorin Expression in Tenocytes Depend On

    Wagenhäuser et al. BMC Musculoskeletal Disorders 2012, 13:140 http://www.biomedcentral.com/1471-2474/13/140 RESEARCH ARTICLE Open Access Collagen type I and decorin expression in tenocytes depend on the cell isolation method Markus U Wagenhäuser1†, Matthias F Pietschmann1*†, Birte Sievers1, Denitsa Docheva2, Matthias Schieker2, Volkmar Jansson1 and Peter E Müller1 Abstract Backround: The treatment of rotator cuff tears is still challenging. Tendon tissue engineering (TTE) might be an alternative in future. Tenocytes seem to be the most suitable cell type as they are easy to obtain and no differentiation in vitro is necessary. The aim of this study was to examine, if the long head of the biceps tendon (LHB) can deliver viable tenocytes for TTE. In this context, different isolation methods, such as enzymatic digestion (ED) and cell migration (CM), are investigated on differences in gene expression and cell morphology. Methods: Samples of the LHB were obtained from patients, who underwent surgery for primary shoulder arthroplasty. Using ED as isolation method, 0.2% collagenase I solution was used. Using CM as isolation method, small pieces of minced tendon were put into petri-dishes. After cell cultivation, RT-PCR was performed for collagen type I, collagen type III, decorin, tenascin-C, fibronectin, Scleraxis, tenomodulin, osteopontin and agreccan. Results: The total number of isolated cells, in relation to 1 g of native tissue, was 14 times higher using ED. The time interval for cell isolation was about 17 hours using ED and approximately 50 days using CM. Cell morphology in vitro was similar for both isolation techniques. Higher expression of collagen type I could be observed in tenocyte-like cell cultures (TLCC) using ED as isolation method (p < 0.05), however decorin expression was higher in TLCC using CM as isolation method (p < 0.05).
  • Re-Evaluation of Lysyl Hydroxylation in the Collagen Triple Helix

    Re-Evaluation of Lysyl Hydroxylation in the Collagen Triple Helix

    bioRxiv preprint doi: https://doi.org/10.1101/2019.12.16.877852; this version posted December 16, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 1 Re-evaluation of lysyl hydroxylation in the collagen triple helix: lysyl hydroxylase 1 and prolyl 3- 2 hydroxylase 3 have site-differential and collagen type-dependent roles in lysine hydroxylation. 3 4 Short title: Two distinct mechanisms of LH1and P3H3 during collagen biosynthesis in the rER 5 6 Yoshihiro Ishikawa1,2,#,*, Yuki Taga3, Keith Zientek2, $, Nobuyo Mizuno2, ¶, Antti M. Salo4, Olesya 7 Semenova2, Sara Tufa2, Douglas R. Keene2, Paul Holden2, Kazunori Mizuno3, Johanna Myllyharju4 and 8 Hans Peter Bächinger1 9 10 1: Department of Biochemistry and Molecular Biology, Oregon Health & Science University, Portland, 11 Oregon, USA, 2: Shriners Hospital for Children, Research Department, Portland, Oregon, USA, 3: Nippi 12 Research Institute of Biomatrix, Ibaraki, Japan, 4: Oulu Center for Cell-Matrix Research, Biocenter Oulu 13 and Faculty of Biochemistry and Molecular Medicine, University of Oulu, Oulu, Finland. 14 15 Present address; #: Departments of Ophthalmology, University of California San Francisco, School of 16 Medicine, California, USA, $: Proteomics core facility, Oregon Health & Science University, Portland, 17 Oregon, USA, ¶: Vaccine and Gene Therapy Institute, Oregon Health and Science University, Portland, 18 Oregon, USA. 19 20 *: Corresponding author: Yoshihiro Ishikawa, Ph.D., Department of Ophthalmology, University of 21 California, San Francisco, School of Medicine, California, USA; 22 Tel: (503) 866-5940, E-mail: [email protected] 23 ORCID-ID: https://orcid.org/0000-0003-2013-0518 24 25 Competing Interests: The authors declare that they have no competing interests related to this work 1 bioRxiv preprint doi: https://doi.org/10.1101/2019.12.16.877852; this version posted December 16, 2019.
  • Lysyl Hydroxylases 1 and 2

    Lysyl Hydroxylases 1 and 2

    D 1159 OULU 2012 D 1159 UNIVERSITY OF OULU P.O.B. 7500 FI-90014 UNIVERSITY OF OULU FINLAND ACTA UNIVERSITATIS OULUENSIS ACTA UNIVERSITATIS OULUENSIS ACTA SERIES EDITORS DMEDICA Marjo Hyry ASCIENTIAE RERUM NATURALIUM Marjo Hyry Senior Assistant Jorma Arhippainen LYSYL HYDROXYLASES 1 AND 2 BHUMANIORA Lecturer Santeri Palviainen CHARACTERIZATION OF THEIR IN VIVO ROLES IN MOUSE AND THE MOLECULAR LEVEL CTECHNICA CONSEQUENCES OF THE LYSYL HYDROXYLASE 2 Professor Hannu Heusala MUTATIONS FOUND IN BRUCK SYNDROME DMEDICA Professor Olli Vuolteenaho ESCIENTIAE RERUM SOCIALIUM Senior Researcher Eila Estola FSCRIPTA ACADEMICA Director Sinikka Eskelinen GOECONOMICA Professor Jari Juga EDITOR IN CHIEF Professor Olli Vuolteenaho PUBLICATIONS EDITOR Publications Editor Kirsti Nurkkala UNIVERSITY OF OULU GRADUATE SCHOOL; UNIVERSITY OF OULU, FACULTY OF MEDICINE, INSTITUTE OF BIOMEDICINE, ISBN 978-951-42-9841-7 (Paperback) DEPARTMENT OF MEDICAL BIOCHEMISTRY AND MOLECULAR BIOLOGY; ISBN 978-951-42-9842-4 (PDF) BIOCENTER OULU; ISSN 0355-3221 (Print) CENTER FOR CELL-MATRIX RESEARCH ISSN 1796-2234 (Online) ACTA UNIVERSITATIS OULUENSIS D Medica 1159 MARJO HYRY LYSYL HYDROXYLASES 1 AND 2 Characterization of their in vivo roles in mouse and the molecular level consequences of the lysyl hydroxylase 2 mutations found in Bruck syndrome Academic dissertation to be presented with the assent of the Doctoral Training Committee of Health and Biosciences of the University of Oulu for public defence in Auditorium F101 of the Department of Physiology (Aapistie 7), on 8 June 2012, at 10 a.m. UNIVERSITY OF OULU, OULU 2012 Copyright © 2012 Acta Univ. Oul. D 1159, 2012 Supervised by Professor Johanna Myllyharju Reviewed by Professor Heather Yeowell Professor Helen Skaer ISBN 978-951-42-9841-7 (Paperback) ISBN 978-951-42-9842-4 (PDF) ISSN 0355-3221 (Printed) ISSN 1796-2234 (Online) Cover Design Raimo Ahonen JUVENES PRINT TAMPERE 2012 Hyry, Marjo, Lysyl hydroxylases 1 and 2.
  • Collagens—Structure, Function, and Biosynthesis

    Collagens—Structure, Function, and Biosynthesis

    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by University of East Anglia digital repository Advanced Drug Delivery Reviews 55 (2003) 1531–1546 www.elsevier.com/locate/addr Collagens—structure, function, and biosynthesis K. Gelsea,E.Po¨schlb, T. Aignera,* a Cartilage Research, Department of Pathology, University of Erlangen-Nu¨rnberg, Krankenhausstr. 8-10, D-91054 Erlangen, Germany b Department of Experimental Medicine I, University of Erlangen-Nu¨rnberg, 91054 Erlangen, Germany Received 20 January 2003; accepted 26 August 2003 Abstract The extracellular matrix represents a complex alloy of variable members of diverse protein families defining structural integrity and various physiological functions. The most abundant family is the collagens with more than 20 different collagen types identified so far. Collagens are centrally involved in the formation of fibrillar and microfibrillar networks of the extracellular matrix, basement membranes as well as other structures of the extracellular matrix. This review focuses on the distribution and function of various collagen types in different tissues. It introduces their basic structural subunits and points out major steps in the biosynthesis and supramolecular processing of fibrillar collagens as prototypical members of this protein family. A final outlook indicates the importance of different collagen types not only for the understanding of collagen-related diseases, but also as a basis for the therapeutical use of members of this protein family discussed in other chapters of this issue. D 2003 Elsevier B.V. All rights reserved. Keywords: Collagen; Extracellular matrix; Fibrillogenesis; Connective tissue Contents 1. Collagens—general introduction ............................................. 1532 2. Collagens—the basic structural module.........................................
  • Sources of Collagen for Biomaterials in Skin Wound Healing

    Sources of Collagen for Biomaterials in Skin Wound Healing

    bioengineering Review Sources of Collagen for Biomaterials in Skin Wound Healing Evan Davison-Kotler 1,2, William S. Marshall 1 and Elena García-Gareta 2,* 1 Biology Department, St. Francis Xavier University, Antigonish, NS B2G 2W5, Canada 2 Regenerative Biomaterials Group, The RAFT Institute, Mount Vernon Hospital, Northwood HA6 2RN, UK * Correspondence: [email protected]; Tel.: +44-(0)-1923844350 Received: 23 May 2019; Accepted: 26 June 2019; Published: 30 June 2019 Abstract: Collagen is the most frequently used protein in the fields of biomaterials and regenerative medicine. Within the skin, collagen type I and III are the most abundant, while collagen type VII is associated with pathologies of the dermal–epidermal junction. The focus of this review is mainly collagens I and III, with a brief overview of collagen VII. Currently, the majority of collagen is extracted from animal sources; however, animal-derived collagen has a number of shortcomings, including immunogenicity, batch-to-batch variation, and pathogenic contamination. Recombinant collagen is a potential solution to the aforementioned issues, although production of correctly post-translationally modified recombinant human collagen has not yet been performed at industrial scale. This review provides an overview of current collagen sources, associated shortcomings, and potential resolutions. Recombinant expression systems are discussed, as well as the issues associated with each method of expression. Keywords: collagen; collagen sources; recombinant collagen; biomaterials; regenerative medicine; tissue engineering; wound healing; skin 1. Introduction 1.1. The Molecular Structure of Collagen The 28 different collagen types of the collagen superfamily are further divided into eight subfamilies, with the majority of the collagen types belonging to the fibril-forming or fibrillar subfamily [1,2].
  • Collagen Content and AHMED M

    Collagen Content and AHMED M

    Collagen content and AHMED M. ABU EL-ASRAR, KAREL GEBOES, types in trachomatous SOLIMAN A. AL-KHARASHI, KHALID F. TABBARA, LUC MISSOTTEN conjunctivitis Abstract chronic progressive conjunctival cicatrisation in trachoma that lead to blindness remain unclear. Purpose To study alterations in conjunctival However, previous immunohistochemical collagen in the conjunctiva of patients with studies demonstrated that the tissue damage active trachoma. might result from immunological Methods We studied conjunctival biopsy 3 s mechanisms. - specimens obtained from nine subjects with The metabolic alterations of extracellular active trachoma and from four control matrix components in trachoma may be the subjects. We used immunohistochemical result of cytokines released by resident techniques and a panel of monoclonal and conjunctival cells and by numerous polyclonal antibodies directed against types I, 6 inflammatory cell types infiltrating the tissue. III, IV and V collagen. The banded collagen fibrils are the most Results In normal conjunctiva, the staining for abundant and widely distributed matrix types I and III collagen was localised to the components. Increased collagen content is a substantia propria. Type IV collagen was feature of many inflammatory and located in the epithelial and capillary fibroproliferative diseases?-17 endothelial basement membranes. The We analysed conjunctival biopsy specimens staining for type V collagen was absent. In from patients with active trachoma in order to trachoma biopsy specimens, staining for types determine some of the mechanisms that control I and III collagen showed collagen fibrils conjunctival scarring. Using among epithelial cells, patchy increase in immunohistochemical methods we examined staining intensity in the upper stroma, and the ature and distribution of types I, III, IV thicker and irregularly arranged collagen n and A.M.